RayzeBio, Inc.·4

Nov 17, 6:36 PM ET

Moran Susan 4

4 · RayzeBio, Inc. · Filed Nov 17, 2023

Insider Transaction Report

Form 4
Period: 2023-11-17
Moran Susan
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-11-17+164,000164,000 total
    Exercise: $22.72Exp: 2033-11-16Common Stock (164,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option vest in a series of 48 successive equal monthly installments over the four-year period measured from the date of grant.

Documents

1 file
  • 4
    wk-form4_1700264163.xmlPrimary

    FORM 4